CLINICAL_TRIALS
trial_result
· 2012-05-15
Clinical Trial Update: Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis [Phase 4]
Summary
This Phase 4 trial examined how atorvastatin modulates systemic immune responses and how pharmacogenetics influence its effects in early atherosclerosis; result…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Florida | Conditions: Inflammation | Phase 4 | Status: COMPLETED | Results posted: 2012-05-15